HIV treatment & latest research

Dr. Kimberly Smith, Head of Global Research and Medical Strategy at ViiV Healthcare, discusses the latest advances and research on the challenges facing patients with HIV.

As the head of global research and medical strategy for ViiV Healthcare, Dr. Kimberly Smith MD, MPH oversees the clinical development of ViiV’s pipeline assets in support of the company’s overall company strategy to deliver meaningful advances in treatment and care for people living with HIV. Dr. Smith is a graduate of the University of Michigan School of Medicine and also holds an MPH degree from the University of Michigan School of Public Health. She completed her internship, residency, and Infectious Disease fellowship at Rush University Medical Centre in Chicago. Following her training, she joined the faculty of the Section of Infectious Disease at Rush University Medical Center in Chicago.

Prior to joining ViiV Healthcare in late 2013, Dr. Smith served as the Principle Investigator of the Rush University Medical Center Clinical Research Site of the AIDS Clinical Trials Group (ACTG). Dr. Smith also served as the chair of the ACTG Underrepresented Populations committee and chair of multiple ACTG clinical trials. She has been a member of NIH study sections, the HIVMA Board of Directors, the CDC Board of Scientific Counselors and numerous advisory committees. Dr. Smith has published over 100 articles, abstracts, and manuscripts and she co-edited one of the few books, HIV/AIDS in U.S. Communities of Color, which addressed the HIV epidemic among minorities in the U.S.

In addition to her research activities, Dr. Smith has been an active HIV clinician, clinical educator, community leader, and advocate. She has lectured at countless local national and international conferences including the Conference on Retroviruses and Opportunistic Infections (CROI), the International AIDS Conference, The International Conference on Antimicrobial Agents and Chemotherapy, and Infectious Disease Society of America.